Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.

Wang Y L, Zhu C, Kapoor M, Cutter G, Barnett-Tapia C, Butzkueven H, Zhang W, Lovas G, Rozsa C, Heckmann J, et al.